Zenas Biopharma Presents Phase 2 Obexelimab Results In Relapsing
09 Feb 2026 //
GLOBENEWSWIRE
EU Approves Guerbet`s Half-Dose Elucirem for Kids
27 Jan 2026 //
PR NEWSWIRE
Hyperfine Enrolls First Patient To Expand Swoop System Use
15 Jan 2026 //
BUSINESSWIRE
Bayer`s Gadoquatrane Meets Key Endpoints in Kids` Study at RSNA25
03 Dec 2025 //
BUSINESSWIRE
Zenas Autoimmune Drug Prompts 95% Drop In Lesions In MS Study
27 Oct 2025 //
GLOBENEWSWIRE
Bayer Applies for EU Approval of Gadoquatrane MRI Agent
11 Jul 2025 //
INDPHARMAPOST
Nusano Program Enriches Gadolinium-160 to 99.2% Purity
10 Jun 2025 //
GLOBENEWSWIRE
ASP & Isotopia Ink Gadolinium-160 Deal For Tb-161 Cancer Therapy
02 Jun 2025 //
PR NEWSWIRE

Market Place
Sourcing Support